Syndax Pharmaceuticals (SNDX) Tops Q3 EPS by 6c

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q3 EPS of ($0.73), $0.06 better than the analyst estimate of ($0.79).

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• NVE Corporation names new CEO and expands board to seven members
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins